Blood-based-inflammation-markers, body mass index, and survival of nonmetastatic esophageal cancer.

Authors

null

Wanning Wang

Princess Margaret Cancer Center, Toronto, ON, Canada

Wanning Wang , Joelle Soriano , Tyler Soberano , Katrina Hueniken , M. Catherine Brown , Kirsty Taylor , Jaspreet K. Bajwa , George Dong , Eric Xueyu Chen , Jennifer J. Knox , Raymond Woo-Jun Jang , Rebecca Wong , Gail Elizabeth Darling , Wei Xu , Micheal McInnis , Geoffrey Liu , Dmitry Rozenberg , Elena Elimova , Aline Fusco Fares

Organizations

Princess Margaret Cancer Center, Toronto, ON, Canada, Princess Margaret Cancer Centre, Toronto, ON, Canada, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada, University of Toronto, Department of Medical Imaging, Toronto, ON, Canada, Joint Department of Medical Imaging (JDMI), Toronto, ON, Canada, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada, Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada, Toronto General Hospital, Toronto, ON, Canada, University of Texas MD Anderson Cancer Center, Houston, TX, Princess Margaret Hospital, Toronto, ON, Canada

Research Funding

No funding received
None

Background: Blood-based-inflammation-markers (BBIM) and Body Mass Index (BMI) have been associated with overall survival (OS) in a number of cancers. Inflammation and obesity have biological interactions. We evaluated the role of Neutrophil-to-Lymphocyte-Ratio (NLR), Platelet-to-Lymphocyte-Ratio (PLR) and Systemic-Inflammation-Index (SII) in conjunction with BMI as predictors of OS in localized/locally-advanced-esophageal cancer (LEC/LAEC). Methods: LEC/LAEC patients treated from 2006-2014 had the following variables analyzed both as continuous and categorical: BMI (low <25 kg/m2, high ≥25 kg/m2), NLR (low <4, high ≥4), PLR (low <232, high ≥232), and SII (low <1375, high ≥1375), with OS. Univariate (UVA) and Multivariate analysis (MVA) were analyzed using Cox regression (adjusted hazard ratios, aHR; 95% Confidence Intervals, CI). MVA models of OS were built, assessing different categorical combinations of BBIM factors with and without BMI. Results: Of 411 pts, 79% were males, median age was 63.5 years, 67% were adenocarcinomas; Stage I/II/III: 14%, 28%, 59%; Median BMI was 26.5kg/m2 and BMI distribution was: 3% underweight, 40% normal weight, 37% overweight and 20% obese. After a median follow-up of 87 months, 204 pts recurred, and 257 died. In MVA, BMI alone had no impact on OS (aHR 0.89, CI 0.7-1.1, p=0.15); individually as continuous variables, higher SII (p=0.03) and higher NLR (p=0.006) were inversely associated with OS whereas higher PLR was not (p=0.10). In an MVA of categorical combinations of BMI and BBIM on OS, patients in the high-BMI/low-PLR group were at lower risk of death when compared to all other groups (aHR=0.65, 95%CI:0.5-0.8, p=0.007). Similar non-statistically significant trends were shown when SII and NLR were individually combined with BMI (aHR=0.77, 95%CI:0.6-1.0, p=0.09; aHR=0.74, 95%CI:0.5-1.0, p=0.05, respectively). Conclusions: Our results suggest that in LEC/LAEC pts, high BMI and low PLR together are associated with improved OS when compared to pts with low BMI and/or high PLR. NLR and SII alone were associated with OS. Further studies evaluating the underlying mechanisms of BBMI, in particular PLR and inflammation/obesity are warranted.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 324)

Abstract #

324

Poster Bd #

B21

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

Impact of obesity on postoperative outcomes in patients undergoing esophagectomy for resectable esophageal cancer.

First Author: Nikhil Patel

Abstract

2022 ASCO Annual Meeting

The impact of BMI on the response to immunotherapy in lung cancer.

First Author: Yuan Ying

Abstract

2023 ASCO Annual Meeting

Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab.

First Author: Lela Bitar

First Author: Andreas Bello